መነሻ › የኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) › ዲስትሪክት ኦፍ ኮሎምቢያ › Washington
በWashington፣ DC ለየኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) የሚደረጉ ክሊኒካዊ ጥናቶች
ለየኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) የሚደረጉ 13 ጥናቶች በWashington እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 ማይል ርቀት
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- NCI - Center for Cancer Research, Bethesda · 7 ማይል ርቀት
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Sibley Memorial Hospital, Washington D.C.
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Georgetown University, Washington D.C.
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- MedStar Washington Hospital Center, Washington D.C.
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Sibley Memorial Hospital, Washington D.C.
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- MedStar Washington Hospital Center, Washington D.C.
በሌሎች ከተሞች ለየኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) የሚደረጉ ጥናቶች
- Houston, TX35 ጥናቶች
- New York City, NY27 ጥናቶች
- Nashville, TN23 ጥናቶች
- Dallas, TX23 ጥናቶች
- St. Louis, MO23 ጥናቶች
- Los Angeles, CA20 ጥናቶች
- Boston, MA16 ጥናቶች
- Baldwin Park, CA16 ጥናቶች
- Philadelphia, PA15 ጥናቶች
- Pittsburgh, PA15 ጥናቶች
- Queens, NY15 ጥናቶች
- Rochester, MN14 ጥናቶች
በWashington ውስጥ ያሉ ሌሎች ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)58 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር55 ጥናቶች
- የጡንቻ ካንሰር46 ጥናቶች
- Metastatic Cancer43 ጥናቶች
- የሳንባ ካንሰር41 ጥናቶች
- የፕሮስቴት ካንሰር38 ጥናቶች
- ከባድ ሰውነት33 ጥናቶች
- የኮሎሬክታል ካንሰር29 ጥናቶች
- የልብና የደም ዝውውር ሕመም28 ጥናቶች
- የሽንት ፊኛ ካንሰር26 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ24 ጥናቶች
- የእንቁላል ካንሰር23 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።